vimarsana.com

Page 24 - ஒன்றுபட்டது மாநிலங்களில் பத்திரங்கள் பரிமாற்றம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Link Reservations Inc /LinkResPet (LRSV) Developing CBD Product to Combat Pet Obesity

Link Reservations Inc./LinkResPet (LRSV) Developing CBD Product to Combat Pet Obesity London, United Kingdom (Newsfile Corp. - April 21, 2021) - Link Reservations Inc. (OTC Pink: LRSV) (the Company ), a provider of wellness and cannabidiol (CBD) products for both humans and pets, announces it is exploring the development of a new LinkResPet CBD product to aid pets dealing with obesity and weight problems. The new tincture will promote fat loss and increase energy levels in animals. Obesity and weight problems are an existing issue in people s lives, whether they hear about it or encounter it in their lives. However it is not exclusively a human problem, our pets are suffering too. Just in North America, approximately 25-30% of the general canine population is obese, with 40-45% of dogs aged 5-11 years old weighing in higher than normal. As with humans, the additional weight can increase the risks of health issues in the animals lives - from a shortened life expectancy to proble

CBD Pet Stock News: Link Reservations Inc/LinkResPet ($LRSV) Developing CBD Product To Combat Pet Obesity

CBD Pet Stock News: Link Reservations Inc/LinkResPet ($LRSV) Developing CBD Product To Combat Pet Obesity Link Reservations Inc. (OTC: LRSV) announces it s exploring development of a new LinkResPet CBD product to aid pets dealing with obesity and weight problems Link Reservations Inc. (OTCMKTS:LRSV)LONDON, UK, UNITED KINGDOM, April 21, 2021 /EINPresswire.com/ Breaking CBD stock news from Investorideas.com Newswire- Link Reservations Inc. (OTC: LRSV), a provider of wellness and cannabidiol (CBD) products for both humans and pets, announces it is exploring the development of a new LinkResPet CBD product to aid pets dealing with obesity and weight problems. The new tincture will promote fat loss and increase energy levels in animals.

TechnipFMC plc: TechnipFMC Awarded a Significant Subsea Contract for Petrobras Marlim and Voador Fields

TechnipFMC plc: TechnipFMC Awarded a Significant Subsea Contract for Petrobras Marlim and Voador Fields (1) subsea contract from Petrobras (NYSE: PBR) for the Marlim and Voador fields, located offshore Brazil. TechnipFMC will supply up to eight manifolds for production and injection, utilizing the all-electric Robotic Valve Controller (RVC). The contract also includes associated tools, spares and services. The RVC is a unique robotic technology that replaces traditional subsea hydraulics, as well as thousands of mechanical parts, while providing real-time data and analysis on system performance. This results in a manifold that is smaller, less complex and less costly with a significantly reduced carbon footprint. Moreover, the RVC s software can be remotely upgraded and maintained subsea, increasing the overall reliability and availability of the subsea system.

Athena Gold Corporation announces David Beling, P E as Senior Technical Advisor

Athena Gold Corporation announces David Beling, P E as Senior Technical Advisor
theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.

Investegate |4d Pharma PLC Announcements | 4d Pharma PLC: Collaboration with Parkinson s UK

  Leeds, UK, April 19, 2021 - 4D pharma plc (AIM: DDDD; NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome, today announces a collaboration with Parkinson s UK, a non-profit organization focused on advancing the understanding of Parkinson s disease and improving treatments, to establish a Patient Advisory Board. The Patient Advisory Board (PAB) will be comprised of people living with Parkinson s. Supported by Parkinson s UK, the PAB will provide valuable patient-centric perspective to 4D pharma as it continues to advance novel Live Biotherapeutics into the clinic to treat neurodegenerative conditions such as Parkinson s. The PAB will also focus on raising awareness of the issues people with Parkinson s face with current treatment options.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.